4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Radiopharm Theranostics Limited (RADX) operates in the Biotechnology industry and is headquartered in Carlton, Australia. Its market capitalization is roughly $30 million. In the fiscal year ended 2025-06-30, RADX reported AUD 4M in revenue and (AUD 38M) in net income.
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
Interactive charts & full statements → Open the RADX valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | AUD 4M | AUD 0M | AUD 0M | AUD 0M |
| Gross Profit | AUD 0M | AUD 0M | AUD 0M | AUD 0M |
| Operating Income (EBIT) | (AUD 35M) | (AUD 37M) | (AUD 32M) | (AUD 20M) |
| Net Income | (AUD 38M) | (AUD 48M) | (AUD 35M) | (AUD 30M) |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | AUD 86M | AUD 72M | AUD 75M | AUD 83M |
| Total Liabilities | AUD 44M | AUD 45M | AUD 29M | AUD 20M |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RADX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms